Vaishali Pharma Ltd

Vaishali Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaishali Pharma Ltd

₹ 7.92 0.25%
12 Dec - close price
Company website NSE: VAISHALI
About

Incorporated in 1989, Vaishali Pharma Ltd
does marketing of pharmaceutical products including active pharmaceutical ingredients[1]

Key Points

Business Overview:[1]
VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ Brands including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations

Website NSE
  • Market Cap ₹ 103 Cr.
  • Current Price ₹ 7.92
  • High / Low ₹ 20.1 / 7.75
  • Stock P/E
  • Book Value ₹ 5.16
  • Dividend Yield 0.00 %
  • ROCE 4.93 %
  • ROE 1.52 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Debtor days have improved from 221 to 172 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.5% over past five years.
  • Promoter holding is low: 26.3%
  • Company has a low return on equity of 6.31% over last 3 years.
  • Earnings include an other income of Rs.3.75 Cr.
  • Company has high debtors of 172 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
13.16 20.09 26.24 13.42 12.57 27.90 32.40 18.08 20.79 27.91 32.25 23.75 33.45
10.57 16.53 25.46 11.11 9.92 24.95 39.19 15.73 18.37 26.55 38.29 22.38 32.06
Operating Profit 2.59 3.56 0.78 2.31 2.65 2.95 -6.79 2.35 2.42 1.36 -6.04 1.37 1.39
OPM % 19.68% 17.72% 2.97% 17.21% 21.08% 10.57% -20.96% 13.00% 11.64% 4.87% -18.73% 5.77% 4.16%
0.74 0.53 0.53 0.36 0.30 0.47 0.91 0.42 0.71 1.07 1.00 0.84 0.84
Interest 0.53 0.42 0.54 0.43 0.47 0.43 0.40 0.38 0.38 0.38 0.44 0.33 0.40
Depreciation 0.14 0.12 0.15 0.12 0.12 0.12 0.14 0.12 0.12 0.12 0.12 0.14 0.17
Profit before tax 2.66 3.55 0.62 2.12 2.36 2.87 -6.42 2.27 2.63 1.93 -5.60 1.74 1.66
Tax % 24.81% 25.07% 29.03% 25.00% 27.97% 26.13% -26.95% 25.11% 25.10% 24.87% -23.39% 26.44% 28.31%
1.99 2.66 0.44 1.59 1.70 2.11 -4.68 1.70 1.97 1.44 -4.29 1.28 1.18
EPS in Rs 0.19 0.25 0.04 0.15 0.16 0.20 -0.44 0.16 0.18 0.13 -0.40 0.12 0.09
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
121 95 67 64 68 75 60 54 76 70 86 99 117
118 95 66 60 65 73 59 51 69 60 85 98 119
Operating Profit 2 -0 1 3 3 2 1 3 7 9 2 1 -2
OPM % 2% -0% 1% 5% 4% 3% 2% 5% 9% 13% 2% 1% -2%
1 4 3 1 2 2 2 2 2 2 2 3 4
Interest 3 3 3 3 3 3 3 3 2 2 2 2 2
Depreciation 0 0 0 0 0 0 0 0 0 0 1 0 1
Profit before tax 1 0 -0 1 1 1 0 1 6 9 1 1 -0
Tax % 50% -7% 300% 32% 41% 37% 62% 26% 30% 25% 23% 34%
0 0 -0 1 1 1 0 1 4 7 1 1 -0
EPS in Rs 0.38 0.20 -0.04 0.15 0.08 0.07 0.00 0.10 0.38 0.63 0.07 0.08 -0.06
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 0%
5 Years: 11%
3 Years: 9%
TTM: 18%
Compounded Profit Growth
10 Years: 18%
5 Years: 94%
3 Years: -41%
TTM: -135%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: -20%
1 Year: -61%
Return on Equity
10 Years: 7%
5 Years: 8%
3 Years: 6%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.50 0.50 0.50 3 7 7 11 11 11 11 11 26 26
Reserves 3 3 3 1 14 15 11 12 16 30 32 39 41
19 25 21 23 18 17 17 18 21 15 13 12 16
32 17 25 18 25 30 28 46 34 24 24 33 39
Total Liabilities 53 46 49 45 64 69 66 86 82 79 80 110 122
0 2 1 1 1 1 1 1 1 2 2 2 2
CWIP 0 0 0 0 0 0 0 0 0 1 1 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 5
53 44 48 43 62 67 64 84 80 76 77 107 114
Total Assets 53 46 49 45 64 69 66 86 82 79 80 110 122

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-7 -4 5 0 -9 4 3 2 1 1 1 -18
-0 2 3 1 1 -0 -0 -0 -1 0 1 -0
6 2 -8 -1 8 -4 -3 -2 0 -2 -1 18
Net Cash Flow -1 0 0 -0 0 0 0 0 1 -0 1 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 116 133 221 214 240 240 286 453 282 281 209 172
Inventory Days 26 13 20 7 11 5 6 5 4 20 2 20
Days Payable 99 66 145 100 136 130 169 321 163 120 95 116
Cash Conversion Cycle 43 80 96 121 115 115 123 137 122 181 116 77
Working Capital Days 59 98 25 14 97 98 124 146 111 208 169 231
ROCE % 19% 14% 13% 16% 13% 10% 7% 10% 19% 22% 6% 5%

Shareholding Pattern

Numbers in percentages

5 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
26.74% 26.74% 26.74% 26.62% 26.62% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32% 26.32%
0.00% 0.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
73.24% 72.69% 73.26% 73.38% 73.38% 73.68% 73.68% 73.67% 73.68% 73.68% 73.68% 73.68%
No. of Shareholders 8,9549,3769,5739,9839,1819,3909,47918,98327,54628,87428,68227,752

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls